Logo

Abbott Extends Tender Offer for Alere Preferred Stock

Oct 02, 2017 | staff reporter

NEW YORK (GenomeWeb) – Abbott today extended its tender offer to purchase all outstanding shares of Alere's Series B convertible perpetual preferred stock at $402 per share.

The offer has been extended to 11:59 p.m. EST, Oct. 3. It was previously scheduled to expire at 11:59 p.m. EST, Sept. 29, and is being extended to allow additional time for the completion of Abbott's planned $5.3 billion buy of Alere, anticipated to be completed on Oct. 3. Regulators last week cleared the way for the deal. 

Filed under

Business News
Molecular Diagnostics
mergers & acquisitions
tender offer
Abbott
Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.